コーパス検索結果 (１語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 recipient conditioning with an antilymphoid antibody preparation.
2 roid-resistant rejection was managed with an antibody preparation.
3 icient to obtain a modified protein-specific antibody preparation.
4 assess the neutralizing activity of anti-PE antibody preparations.
5 scence microscopy by using several different antibody preparations.
6 to horse and rabbit polyclonal antithymocyte antibody preparations.
7 aluate the relative homogeneity of different antibody preparations.
8 nificantly reduces the use of antilymphocyte antibody preparations.
9 y from IgY fractions of monospecific chicken antibody preparations.
10 acy of different batches of these polyclonal antibody preparations.
11 rified recombinant proteins were used to for antibodies preparation.
12 from affinity-isolated, monospecific chicken antibody preparations and to measure antibody specifical
13 practical considerations preclude the use of antibody preparations as a prophylactic passive immuniza
15 bulins (AThG) are a subset of antilymphocyte antibody preparations derived from the sera of rabbits o
19 tile probes for screening crude and purified antibody preparations for receptor specificity, epitope
20 these data suggest that mucosally delivered antibody preparations may be most effective when combini
23 es for CHS and CHI showed that the resulting antibody preparations provide useful tools for character
24 induction immunosuppression with a depleting antibody preparation reduced rejection, whereas SRL prol
26 be candidates for treatment with a humanized antibody preparation such as daclizumab in the presence
27 therapeutic administration of the polyclonal antibody preparations (TcPAbs) can protect mice against
28 (13% vs. 4%; P=0.03), or to have received an antibody preparation to treat acute rejection (19% vs. 8
32 e precision, aggregate content in monoclonal antibody preparations was measured by AUC-SV and analyze
WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。